Biopharmaceutical Leadership: John Xu, MD, MBA, MS
John brings over two decades of expertise in biopharmaceutical research, business development, and cross-border licensing. A graduate of Shanghai Medical University, John began his career with 14 years of research experience in oncology at Bristol Myers Squibb and CNS at Wyeth.
Building on this scientific foundation, John transitioned into business development roles within China’s leading Contract Research Organizations (CROs), including WuXi AppTec and CrownBio, where he led strategic partnerships and client expansion.
For the past eight years, John has focused on both in-licensing and out-licensing deals across the U.S. and China, facilitating high-impact transactions and acting as a key connector in the global biotech ecosystem.
John also serves as the president of the North America Pharmaceutical Professional Alliance (NAPPA). Our primary mission is to unite biopharmaceutical resources to enhance global collaboration.
Highlights of Leadership & Impact:
• Deep network of over 250 China-based biotech clients
• Business development advisor to 10+ U.S.-based venture capital firms, biotech hubs, and platform companies.
• 5 term sheets in the past 24 months
• Built and maintained a powerful global network:
16,200+ LinkedIn connections
30+ WeChat groups, each with 500 biotech professionals